MYSOLINE

This brand name is authorized in Austria, Australia, Spain, France, Ireland, Malta, Mexico, Netherlands, Turkey, United States, South Africa

Active ingredients

The drug MYSOLINE contains one active pharmaceutical ingredient (API):

1 Primidone UNII 13AFD7670Q - PRIMIDONE

Primidone is an anticonvulsant. Although the precise mode of action of primidone is unknown, in common with other anticonvulsants, effects on the neuronal membrane particularly with respect to alteration of ionic fluxes are likely to play a fundamental role. Read about Primidone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MYSOLINE Tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AA03	Primidone	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AA Barbiturates and derivatives
Discover more medicines within N03AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1939C
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 18498
Country: FR	Base de données publique des médicaments	Identifier(s): 65201684
Country: IE	Health Products Regulatory Authority	Identifier(s): 35300
Country: MT	Medicines Authority	Identifier(s): AA1340/00101, AA1343/00301, AA565/54401
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 40520
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 1880
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680395500020
Country: US	FDA, National Drug Code	Identifier(s): 66490-690, 66490-691
Country: ZA	Health Products Regulatory Authority	Identifier(s): B/2.5/572